Kepos Capital’s Celularity CELU Stock Holding History

Kepos Capital’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-25,000	Closed	-$2.54M	–	573
2021 Q2	$2.54M	Hold	25,000	–	–	0.19%	219
2021 Q1	$2.52M	Hold	25,000	–	–	0.16%	239
2020 Q4	$2.75M	Sell	25,000 -20,000	-44%	-$2.13M	0.24%	156
2020 Q3	$4.72M	Sell	45,000 -57,500	-56%	-$5.95M	0.5%	80
2020 Q2	$10.5M	Buy	102,500 +60,000	+141%	+$5.96M	1.36%	27
2020 Q1	$4.17M	Buy	42,500 +6,500	+18%	+$643K	0.87%	44
2019 Q4	$3.58M	Hold	36,000	–	–	0.34%	56
2019 Q3	$3.54M	Buy	+36,000	New	+$3.53M	0.35%	52

Other funds holding CELU

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Kepos Capital's CELU Position: Q3 2021 in Review

Kepos Capital sold out of Celularity (CELU) in Q3 2021, closing a stake of 25,000 shares — an estimated $2.54M sold.

Kepos Capital first reported a position in CELU in Q3 2019 and held it in 8 quarters. The position peaked at $10.5M in Q2 2020. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

Kepos Capital reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
Kepos Capital sold 25,000 Celularity shares in Q3 2021, an estimated $2.54M.
Kepos Capital first reported a position in Celularity in Q3 2019 and held it in 8 quarters.
Kepos Capital's Celularity position peaked at $10.5M in Q2 2020.
21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on Kepos Capital's 13F filing for Q3 2021, filed 12 Nov 2021.